When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...
Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.
Hosted on MSN
JPMorgan boosts rating on Recursion Pharmaceuticals (RXRX) amid AI-driven drug pipeline
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, JPMorgan raised Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from a Neutral ...
Saudi Aramco leads in market cap at $1.61 trillion, distinct from others like ExxonMobil and Chevron. ExxonMobil and Chevron focus on both traditional and renewable energy sources. PetroChina and ...
The auto insurance industry is continuing to consolidate: According to the National Association of Insurance Commissioners, the five largest insurers accounted for nearly two-thirds (63.59%) of the ...
A $1.817 billion Powerball prize won on Christmas Eve in Arkansas now ranks as the second-largest U.S. lottery jackpot ever. By The New York Times Huge jackpots have become increasingly common in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback